Use of transrectal ultrasonography for assessment of the size and location of prostatic carcinoma in dogs

Research output: Contribution to journalArticle

Abstract

OBJECTIVE To evaluate the use of transrectal ultrasonography (TRUS) for the assessment of prostatic tumors in dogs and to compare results for TRUS with results for other imaging modalities. ANIMALS 10 client-owned male dogs. PROCEDURES Client-owned dogs identified with prostatic carcinoma were enrolled. Fluoroscopy, transabdominal ultrasonography (TAUS), TRUS, and MRI were performed on all dogs. Tumor measurements, urethral penetration (identification of abnormal tissue within the urethral lumen), and tumor extension into the urinary tract were recorded for all imaging modalities. Agreement between results for MRI (considered the criterion-referenced standard) and results for other modalities were compared. RESULTS Median body weight of the 10 dogs was 26.3 kg (range, 9.4 to 49.5 kg). No complications were encountered during or after TRUS. Significant moderate to good agreements (intraclass correlation coefficients, 0.60 to 0.86) among TAUS, TRUS, fluoroscopy, and MRI were identified for tumor length and height. Assessments of urethral penetration and tumor extension into the bladder with TRUS did not differ significantly from those made with MRI and were superior in terms of absolute agreement with MRI when compared with those for TAUS. CONCLUSIONS AND CLINICAL RELEVANCE TRUS was successfully and safely used to evaluate prostatic carcinoma in dogs. There was moderate to good agreement with MRI results for tumor height and length measurements, and TRUS was found to be superior to TAUS for some assessments. Transrectal ultrasonography can be considered an adjunctive imaging modality for the performance of prostatic inter-ventional procedures or assessment of response to treatment. (Am J Vet Res 2019;80:1012–1019).

Original languageEnglish (US)
Pages (from-to)1012-1019
Number of pages8
JournalAmerican journal of veterinary research
Volume80
Issue number11
DOIs
StatePublished - Nov 2019

Fingerprint

ultrasonography
carcinoma
Ultrasonography
Dogs
Carcinoma
dogs
neoplasms
Neoplasms
Fluoroscopy
image analysis
urinary tract
prostatic neoplasms
Urinary Tract
bladder
Urinary Bladder
Body Weight

ASJC Scopus subject areas

  • veterinary(all)

Cite this

@article{c348ab4f788c4506b7fefa7136d98f8c,
title = "Use of transrectal ultrasonography for assessment of the size and location of prostatic carcinoma in dogs",
abstract = "OBJECTIVE To evaluate the use of transrectal ultrasonography (TRUS) for the assessment of prostatic tumors in dogs and to compare results for TRUS with results for other imaging modalities. ANIMALS 10 client-owned male dogs. PROCEDURES Client-owned dogs identified with prostatic carcinoma were enrolled. Fluoroscopy, transabdominal ultrasonography (TAUS), TRUS, and MRI were performed on all dogs. Tumor measurements, urethral penetration (identification of abnormal tissue within the urethral lumen), and tumor extension into the urinary tract were recorded for all imaging modalities. Agreement between results for MRI (considered the criterion-referenced standard) and results for other modalities were compared. RESULTS Median body weight of the 10 dogs was 26.3 kg (range, 9.4 to 49.5 kg). No complications were encountered during or after TRUS. Significant moderate to good agreements (intraclass correlation coefficients, 0.60 to 0.86) among TAUS, TRUS, fluoroscopy, and MRI were identified for tumor length and height. Assessments of urethral penetration and tumor extension into the bladder with TRUS did not differ significantly from those made with MRI and were superior in terms of absolute agreement with MRI when compared with those for TAUS. CONCLUSIONS AND CLINICAL RELEVANCE TRUS was successfully and safely used to evaluate prostatic carcinoma in dogs. There was moderate to good agreement with MRI results for tumor height and length measurements, and TRUS was found to be superior to TAUS for some assessments. Transrectal ultrasonography can be considered an adjunctive imaging modality for the performance of prostatic inter-ventional procedures or assessment of response to treatment. (Am J Vet Res 2019;80:1012–1019).",
author = "Culp, {William T.N.} and Johnson, {Eric G.} and Giuffrida, {Michelle A.} and Palm, {Carrie A.} and Mayhew, {Philipp D.} and Kent, {Michael S.} and Rebhun, {Robert B.} and Burton, {Jenna H.}",
year = "2019",
month = "11",
doi = "10.2460/ajvr.80.11.1012",
language = "English (US)",
volume = "80",
pages = "1012--1019",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "11",

}

TY - JOUR

T1 - Use of transrectal ultrasonography for assessment of the size and location of prostatic carcinoma in dogs

AU - Culp, William T.N.

AU - Johnson, Eric G.

AU - Giuffrida, Michelle A.

AU - Palm, Carrie A.

AU - Mayhew, Philipp D.

AU - Kent, Michael S.

AU - Rebhun, Robert B.

AU - Burton, Jenna H.

PY - 2019/11

Y1 - 2019/11

N2 - OBJECTIVE To evaluate the use of transrectal ultrasonography (TRUS) for the assessment of prostatic tumors in dogs and to compare results for TRUS with results for other imaging modalities. ANIMALS 10 client-owned male dogs. PROCEDURES Client-owned dogs identified with prostatic carcinoma were enrolled. Fluoroscopy, transabdominal ultrasonography (TAUS), TRUS, and MRI were performed on all dogs. Tumor measurements, urethral penetration (identification of abnormal tissue within the urethral lumen), and tumor extension into the urinary tract were recorded for all imaging modalities. Agreement between results for MRI (considered the criterion-referenced standard) and results for other modalities were compared. RESULTS Median body weight of the 10 dogs was 26.3 kg (range, 9.4 to 49.5 kg). No complications were encountered during or after TRUS. Significant moderate to good agreements (intraclass correlation coefficients, 0.60 to 0.86) among TAUS, TRUS, fluoroscopy, and MRI were identified for tumor length and height. Assessments of urethral penetration and tumor extension into the bladder with TRUS did not differ significantly from those made with MRI and were superior in terms of absolute agreement with MRI when compared with those for TAUS. CONCLUSIONS AND CLINICAL RELEVANCE TRUS was successfully and safely used to evaluate prostatic carcinoma in dogs. There was moderate to good agreement with MRI results for tumor height and length measurements, and TRUS was found to be superior to TAUS for some assessments. Transrectal ultrasonography can be considered an adjunctive imaging modality for the performance of prostatic inter-ventional procedures or assessment of response to treatment. (Am J Vet Res 2019;80:1012–1019).

AB - OBJECTIVE To evaluate the use of transrectal ultrasonography (TRUS) for the assessment of prostatic tumors in dogs and to compare results for TRUS with results for other imaging modalities. ANIMALS 10 client-owned male dogs. PROCEDURES Client-owned dogs identified with prostatic carcinoma were enrolled. Fluoroscopy, transabdominal ultrasonography (TAUS), TRUS, and MRI were performed on all dogs. Tumor measurements, urethral penetration (identification of abnormal tissue within the urethral lumen), and tumor extension into the urinary tract were recorded for all imaging modalities. Agreement between results for MRI (considered the criterion-referenced standard) and results for other modalities were compared. RESULTS Median body weight of the 10 dogs was 26.3 kg (range, 9.4 to 49.5 kg). No complications were encountered during or after TRUS. Significant moderate to good agreements (intraclass correlation coefficients, 0.60 to 0.86) among TAUS, TRUS, fluoroscopy, and MRI were identified for tumor length and height. Assessments of urethral penetration and tumor extension into the bladder with TRUS did not differ significantly from those made with MRI and were superior in terms of absolute agreement with MRI when compared with those for TAUS. CONCLUSIONS AND CLINICAL RELEVANCE TRUS was successfully and safely used to evaluate prostatic carcinoma in dogs. There was moderate to good agreement with MRI results for tumor height and length measurements, and TRUS was found to be superior to TAUS for some assessments. Transrectal ultrasonography can be considered an adjunctive imaging modality for the performance of prostatic inter-ventional procedures or assessment of response to treatment. (Am J Vet Res 2019;80:1012–1019).

UR - http://www.scopus.com/inward/record.url?scp=85074108250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074108250&partnerID=8YFLogxK

U2 - 10.2460/ajvr.80.11.1012

DO - 10.2460/ajvr.80.11.1012

M3 - Article

C2 - 31644342

AN - SCOPUS:85074108250

VL - 80

SP - 1012

EP - 1019

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 11

ER -